Morton W E
J Occup Med. 1977 Mar;19(3):197-200.
The symptoms of acute aliphatic nitrate toxicity are the same whether the exposure was to excess clinical medication or to percutaneous absorption during manufacture or packaging. In industrial exposures there is good evidence of chronic toxicity, with hazards of (a) increased risk of coronary pain and sudden death after withdrawal, and (b) increased risk of sustained hypertension in predisposed persons. On this basis we must suspect that certain types of therapy with aliphatic nitrate drugs might aggravate the course of coronary heart disease or hypertension. Should not these drugs be removed from the market until their long-term safety has been proved? Industrial experience with these chemicals has been incompletely reported, and more data are needed.
急性脂肪族硝酸盐中毒的症状是相同的,无论接触是由于过量临床用药,还是在制造或包装过程中经皮吸收。在工业接触中,有充分证据表明存在慢性毒性,其危害包括:(a)停药后冠心病疼痛和猝死风险增加;(b)易感人群患持续性高血压的风险增加。基于此,我们必须怀疑某些类型的脂肪族硝酸盐药物治疗可能会加重冠心病或高血压的病程。在证明其长期安全性之前,这些药物是否不应从市场上撤下?关于这些化学品的工业经验报告并不完整,需要更多数据。